Yogurt and Cardiometabolic Diseases: A Critical Review of Potential Mechanisms

被引:65
|
作者
Fernandez, Melissa Anne [1 ,2 ,3 ]
Panahi, Shirin [4 ]
Daniel, Noemie [1 ,2 ,3 ]
Tremblay, Angelo [1 ,3 ,4 ]
Marette, Andre [1 ,2 ,5 ]
机构
[1] Univ Laval, Heart & Lung Inst Quebec, Quebec City, PQ, Canada
[2] Univ Laval, Inst Nutr & Funct Foods, Quebec City, PQ, Canada
[3] Univ Laval, Fac Agr & Food Sci, Sch Nutr, Quebec City, PQ, Canada
[4] Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ, Canada
[5] Univ Laval, Fac Med, Dept Med, Quebec City, PQ, Canada
关键词
bioactive peptides; cardiometabolic diseases; dairy; fermented dairy; foodmatrix; hypertension; microbiota; obesity; type; 2; diabetes; yogurt; CONJUGATED LINOLEIC-ACID; DAIRY PRODUCT CONSUMPTION; CHAIN FATTY-ACIDS; DOSE-RESPONSE METAANALYSIS; CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE SYNDROME; ACTIVATED RECEPTOR-ALPHA; FERMENTED FOOD-PRODUCTS; BLOOD-PRESSURE; GUT MICROBIOTA;
D O I
10.3945/an.116.013946
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Associations between yogurt intake and risk of diet-related cardiometabolic diseases (CMDs) have been the subject of recent research in epidemiologic nutrition. A healthy dietary pattern has been identified as a pillar for the prevention of weight gain and CMDs. Epidemiologic studies suggest that yogurt consumption is linked to healthy dietary patterns, lifestyles, and reduced risk of CMDs, particularly type 2 diabetes. However, to our knowledge, few to no randomized controlled trials have investigated yogurt intake in relation to cardiometabolic clinical outcomes. Furthermore, there has been little attempt to clarify the mechanisms that underlie the potential beneficial effects of yogurt consumption on CMDs. Yogurt is a nutrient-dense dairy food and has been suggested to reduce weight gain and prevent CMDs by contributing to intakes of protein, calcium, bioactive lipids, and several other micronutrients. In addition, fermentation with bacterial strains generates bioactive peptides, resulting in a potentially greater beneficial effect of yogurt on metabolic health than nonfermented dairy products such as milk. To date, there is little concrete evidence that the mechanisms proposed in observational studies to explain positive results of yogurt on CMDs or parameters are valid. Many proposed mechanisms are based on assumptions that commercial yogurts contain strain-specific probiotics, that viable yogurt cultures are present in adequate quantities, and that yogurt provides a minimum threshold dose of nutrients or bioactive components capable of exerting a physiologic effect. Therefore, the primary objective of this review is to investigate the plausibility of potential mechanisms commonly cited in the literature in order to shed light on the inverse associations reported between yogurt intake and various cardiometabolic health parameters that are related to its nutrient profile, bacterial constituents, and food matrix. This article reviews current gaps and challenges in identifying such mechanisms and provides a perspective on the research agenda to validate the proposed role of yogurt in protecting against CMDs.
引用
收藏
页码:812 / 829
页数:18
相关论文
共 50 条
  • [1] YOGURT INTAKE AND PREVENTION OF CARDIOMETABOLIC DISEASES: THE ROLE OF FERMENTATION PRODUCTS
    Marette, Andre
    ANNALS OF NUTRITION AND METABOLISM, 2017, 71 : 1330 - 1330
  • [2] New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
    Gallo, Giovanna
    Savoia, Carmine
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (05)
  • [3] Potential Involvement of LncRNAs in Cardiometabolic Diseases
    Ilieva, Mirolyuba
    Uchida, Shizuka
    GENES, 2023, 14 (01)
  • [4] Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies
    Astrup, Arne
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2014, 99 (05): : 1235S - 1242S
  • [5] A systematic review on potential mechanisms of minocycline in kidney diseases
    Hamed Haghi-Aminjan
    Mohammad Hossein Asghari
    Mohammad Hadi Goharbari
    Mohammad Abdollahi
    Pharmacological Reports, 2017, 69 : 602 - 609
  • [6] A systematic review on potential mechanisms of minocycline in kidney diseases
    Haghi-Aminjan, Hamed
    Asghari, Mohammad Hossein
    Goharbari, Mohammad Hadi
    Abdollahi, Mohammad
    PHARMACOLOGICAL REPORTS, 2017, 69 (04) : 602 - 609
  • [7] Mechanisms of autoimmunity in human diseases: a critical review of current dogma
    Benson, Robert A.
    Brewer, James M.
    Platt, Andrew M.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (02) : 197 - 203
  • [8] Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story
    Inceu, Andreea-Ioana
    Neag, Maria-Adriana
    Craciun, Anca-Elena
    Buzoianu, Anca-Dana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [9] The roles and potential mechanisms of plant polysaccharides in liver diseases: a review
    Wei, Xianzhi
    Luo, Daimin
    Li, Haonan
    Li, Yagang
    Cen, Shizhuo
    Huang, Min
    Jiang, Xianxing
    Zhong, Guoping
    Zeng, Weiwei
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications
    Hua, Yinan
    Nair, Sreejayan
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (02): : 195 - 208